1. Home
  2. GKOS vs PDFS Comparison

GKOS vs PDFS Comparison

Compare GKOS & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$115.81

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$29.38

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
PDFS
Founded
1998
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
1.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
PDFS
Price
$115.81
$29.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
4
Target Price
$126.38
$34.50
AVG Volume (30 Days)
694.2K
260.4K
Earning Date
10-29-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$469,820,000.00
$206,706,000.00
Revenue This Year
$31.15
$24.23
Revenue Next Year
$24.15
$19.28
P/E Ratio
N/A
N/A
Revenue Growth
30.38
21.23
52 Week Low
$73.16
$15.91
52 Week High
$163.71
$32.31

Technical Indicators

Market Signals
Indicator
GKOS
PDFS
Relative Strength Index (RSI) 71.98 55.68
Support Level $115.07 $28.35
Resistance Level $117.94 $29.25
Average True Range (ATR) 2.91 1.14
MACD -0.13 -0.17
Stochastic Oscillator 81.29 43.35

Price Performance

Historical Comparison
GKOS
PDFS

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

Share on Social Networks: